Shares of Healios K.K. (OTCMKTS:HLOSF – Get Free Report) were down 28.9% on Thursday . The stock traded as low as $0.96 and last traded at $0.96. Approximately 100 shares traded hands during trading, a decline of 96% from the average daily volume of 2,332 shares. The stock had previously closed at $1.35.
Healios K.K. Stock Down 28.9 %
The firm’s 50 day simple moving average is $1.36 and its two-hundred day simple moving average is $1.39.
About Healios K.K.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.
Further Reading
- Five stocks we like better than Healios K.K.
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- Best Stocks Under $10.00
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- What Are Dividend Contenders? Investing in Dividend Contenders
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
